In this study, TCL+TIO3 induced an increased population of NK cells and higher ratios of CD69+ or NKG2D+ NK cells in splenocytes compared with those of the TCL group, resulting in stronger cytotoxic activities against glioma. The gene discussed is KLRK1; the disease is central nervous system cancer.